Streetbeat News

Stock Prices

MSFT

Investor Business Daily's Swingtrader platform has reportedly purchased shares of Microsoft, indicating a potential positive sentiment towards the stock.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 3:01 pm

ARBUSD

Arbitrum (CRYPTO: ARB) has seen a significant price increase of 14.4% in the last 24 hours, reaching $1.95. Over the past week, it has gained 4.0%, rising from $1.87. The coin's all-time high is $2.11. Despite the price increase, trading volume has decreased by 31.0% over the past week. The circulating supply remains at 1.27 billion, which is 12.75% of the maximum supply. Arbitrum's market cap is currently ranked #37, valued at $2.49 billion.

Portfolio Pulse from Benzinga Insights

January 10, 2024 | 3:01 pm

DXCM

Over the past 15 years, DexCom (NASDAQ:DXCM) has significantly outperformed the market, with an average annual return of 40.59%. A $1000 investment in DexCom 15 years ago would now be worth $167,354.84. DexCom's market capitalization currently stands at $49.65 billion. The article highlights the impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

January 10, 2024 | 3:00 pm

ORCL

Over the past 20 years, Oracle (NYSE:ORCL) has produced an average annual return of 10.22%, outperforming the market by 2.83% on an annualized basis. A $100 investment in ORCL stock 20 years ago would be worth $692.96 today. Oracle's market capitalization currently stands at $283.08 billion. The key takeaway is the significant impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

January 10, 2024 | 3:00 pm

IDYA

RBC Capital analyst Gregory Renza has maintained an Outperform rating on IDEAYA Biosciences (NASDAQ:IDYA) and increased the price target from $36 to $43, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 3:00 pm

STETHUSD

Lido Staked Ether (STETH) has seen a 5.64% increase in price over the past 24 hours, reaching $2,380.87, and an 8.0% increase over the past week. Despite a decrease in trading volume by 24.0%, the circulating supply has slightly increased. STETH's market cap is currently ranked #8 at $22.14 billion.

Portfolio Pulse from Benzinga Insights

January 10, 2024 | 3:00 pm

SANA

Shares of Sana Biotechnology were halted due to a circuit breaker after experiencing a sharp increase, with the stock price surging by 46.9%.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 2:57 pm

CMND

Clearmind Medicine Inc (NASDAQ:CMND) stock soared after announcing the completion of a Type A meeting with the FDA regarding its clinical trial for CMND-100, a compound for treating Alcohol Use Disorder with psychedelic-based therapy. The active ingredient, MEAI, is reported to reduce alcohol consumption desires while providing a euphoric experience. The company aims to resubmit its IND for CMND-100 and bring new treatment options for AUD.

Portfolio Pulse from Adam Eckert

January 10, 2024 | 2:57 pm

QQQ

SPY

TLT

The upcoming December inflation report is critical for the Federal Reserve's rate decisions in Q1 2024. Economists expect a slight increase in annual CPI to 3.2% from November's 3.1%, with core CPI predicted to decline to 3.8% from 4%. Goldman Sachs projects slightly higher rates, while Bank of America aligns with consensus and suggests a potential rate cut in March if inflation is softer than expected. November's CPI report aligned with forecasts, leading to gains in SPY and QQQ, and a rise in TLT as Treasury yields fell.

Portfolio Pulse from Piero Cingari

January 10, 2024 | 2:45 pm

BTB

Bit Brother shares have resumed trading, but the article does not provide additional context or information regarding the reasons for the trade resumption or any events surrounding the company that could affect its stock price.

Portfolio Pulse from Benzinga Newsdesk

January 10, 2024 | 2:43 pm